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Abstract
Background: The Experimental Factor Ontology (EFO) is an application ontology driven by experimental variables
including cell lines to organize and describe the diverse experimental variables and data resided in the EMBL-EBI
resources. The Cell Line Ontology (CLO) is an OBO community-based ontology that contains information of
immortalized cell lines and relevant experimental components. EFO integrates and extends ontologies from the
bio-ontology community to drive a number of practical applications. It is desirable that the community shares design
patterns and therefore that EFO reuses the cell line representation from the Cell Line Ontology (CLO). There are,
however, challenges to be addressed when developing a common ontology design pattern for representing cell
lines in both EFO and CLO.
Results: In this study, we developed a strategy to compare and map cell line terms between EFO and CLO. We
examined Cellosaurus resources for EFO-CLO cross-references. Text labels of cell lines from both ontologies were
verified by biological information axiomatized in each source. The study resulted in the identification 873 EFO-
CLO aligned and 344 EFO unique immortalized permanent cell lines. All of these cell lines were updated to CLO
and the cell line related information was merged. A design pattern that integrates EFO and CLO was also
developed.
Conclusion: Our study compared, aligned, and synchronized the cell line information between CLO and EFO. The final
updated CLO will be examined as the candidate ontology to import and replace eligible EFO cell line classes
thereby supporting the interoperability in the bio-ontology domain. Our mapping pipeline illustrates the use of
ontology in aiding biological data standardization and integration through the biological and semantics content of
cell lines.
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Background
Tens of thousands of cell lines have been developed and
used in experimental research, making the usage of cell
lines a major tool for scientific discovery. A biomedical
ontology is a set of human- and computer-interpretable
terms and relations that represents various entities and
the relations among these entities in a biomedical do-
main. Biomedical ontologies are critical to data and
knowledge representation, standardization, integration,
and computer-assisted reasoning. To better support cell
line-based research, it is critical to have a standardized
ontology that represents available cell lines, their associ-
ated cell types, tissues, and diseases, and how these en-
tities connect to each other.
The Experimental Factor Ontology (EFO) is a data-
driven biomedical application ontology developed by the
European Bioinformatics Institute (EMBL-EBI) to organize
the diverse experimental variables needed to describe data
resided in the EMBL-EBI resources, including cell line
data [1]. EFO aims to build on and extend existing refer-
ence ontologies from the OBO foundry, such as the Hu-
man Phenotype Ontology [2] and the Uberon anatomy
ontology [3], and uses a number of design patterns to inte-
grate and cross-link these ontologies. EFO includes many
cell lines that were created to annotate cell lines from ex-
periments in the Array Express archive [4]. Aligning the
EFO cell lines with the community-based Cell Line Ontol-
ogy (CLO), which describes immortalized cell lines [5],
would enable semantic alignment of cell lines and associ-
ated datasets. There also exist other resources that attempt
to bridge cell line information from EFO and CLO to-
gether, such as Cellosaurus [6]. Cellosaurus is a manually
curated knowledgebase of cell line resources for biomed-
ical research, and it provides high quality cross references
to other resources including EFO and CLO, which can be
used to facilitate cross-linking between the two resources.
Currently, EFO cell line is loosely defined as a popula-
tion of cell units and covers primary cell lines as well as
permanent cell lines under ‘material entity’. On the
other hand, CLO defines characteristics of cell line at a
single-cell level and aims to cover the immortalized
stable cell lines. With the different conceptual viewpoint
of EFO and CLO cell lines, the population level defin-
ition of EFO cell line is suitable to model experiments
where measurement is performed on cell line cultures.
Even though cell line cultures were assumed homoge-
neous, recent studies reviewed the effects of heterogen-
eity of cells within the same culture [7–9]. The analysis
of single-cell dynamics in the culture can increase our
understanding of cellular level interaction and provides a
better assessment of cell behavior in the culture. Thus,
CLO’s cell line definition as individual cells comple-
ments data modeling of single-cell experiment. The dif-
ferent aspects of cell lines in CLO and EFO (individual
cell versus population of cells) are complementary com-
ponents of each other to describe a cell line related in-
formation, knowledge integration and collaboration. The
complementary modeling of both approaches has been
discussed in the CLO paper [5].
Besides the difference in the definition of individual-level
and population-level of cell lines, EFO and CLO also have
different coverages. EFO covers primary cell lines, stem cell
derived cell lines, and immortalized permanent cell lines
that can be cross-referenced with central cell line catalogs,
while CLO only covers immortalized permanent cell lines.
While the aim of this study is to align cell lines in CLO
and EFO, cell lines that do not belong to the immortalized
permanent cell lines mapping described above should re-
main in the scope of EFO-native primary cell lines.
In this study, we have developed a mapping process that
combines third-party cross referencing, lexical and bio-
logical content comparison, and semantic relation match-
ing to compare, align and synchronize immortalized
permanent cell lines available in EFO and CLO. This will
allow for a better cell line knowledge integration within
the scope of the OBO Foundry [10]. Additional cell line
information obtained from EFO, such as organs and dis-
eases, will be incorporated into CLO using the design pat-
tern developed in this study. Cellosaurus was used as a
high-quality third-party cell line resource to verify map-
ping between EFO and CLO, as well as the identification
of immortalized permanent cell lines in EFO to be in-
cluded in CLO. The information of EFO-CLO aligned cell
line will be merged from the two ontologies. Mapped EFO
cell line classes will be deprecated and replaced by the
corresponding CLO cell line classes with CLO namespace.
Additional immortalized permanent cell lines from EFO
will be added to CLO and assigned with new CLO URIs.
This work resulted in an updated CLO ontology with
EFO-CLO aligned information which will be used as the
source ontology for cell lines in future EFO’s production.
Methods
Data preparation
The input ontology OWL files of EFO (version 2.85) and
CLO (version 2.1.106) were downloaded from Ontobee
[11] and the text format of Cellosaurus (version 22.0) was
downloaded from ExPASy portal [12]. Additionally, EFO
cell lines that were drawn from external sources (e.g.,
CLO and BRENDA Tissue and Enzyme Source Ontology
(BTO) [13]) were excluded (Additional file 1: Table S1)
from the mapping process as the aim of this study is to
map EFO-namespaced cell lines to referenced CLO cell
lines. Cell lines and its annotations (label, synonyms and
cross references) under EFO’s ‘cell line’ class, CLO’s ‘cell
line cell’ class and all Cellosaurus cell lines, along with the
related biological information (disease, cell type, anatom-
ical location and species of origin), were extracted as
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Fig. 1 General project workflow. The general pipeline of comparing, aligning and synchronizing cell lines between EFO (version 2.85) and CLO
(version 2.1.106) with additional information downloaded from Cellosaurus (version 22.0).The workflow was separated into four major steps (indicated as
blue circles). Step 1: Cell lines and related biological information were downloaded and extracted from EFO, CLO and Cellosaurus. Step 2: Comparison
and alignment of EFO cell lines to CLO through three intermediate processes: (i) EFO-Cellosaurus-CLO Mapping that performed cross-references
and validations among the three cell line resources; (ii) Direct EFO-CLO Mapping that compared and mapped EFO cell lines to all CLO cell lines; (iii)
Identification of EFO unique Cell Lines that were immortalized permanent cell lines not available in CLO. The results of (i)-(iii) were summarized
in Fig. 4.EFO cell lines with foreign (non-EFO) namespace such as Brenda Tissue Ontology (BTO), stem cell lines and primary cell lines were excluded
from the mapping and remained in EFO. The overall mapping result was summarized in Table 1. Step 3: The mapped EFO-CLO cell lines and
EFO unique immortalized permanent cell lines would be merged or added to CLO. Step 4: The updated and synchronized CLO will later be
imported to EFO immortalized permanent cell line module
Fig. 2 Comparison of EFO and CLO cell line design patterns. The EFO cell line design pattern was colored in orange and CLO in blue. The green
color indicated cell line related information and design pattern shared in both EFO and CLO design patterns
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depicted in Fig. 1 Step 1 (blue circle). Specifically, for EFO
and CLO, the cell line related information was stored as
semantic axioms with different design patterns as illus-
trated in Fig. 2. The rationale of examining both lexical
contents and biological information is to ensure the map-
ping accuracy between CLO and EFO cell lines. Two cell
lines of an identical or very similar label do not always
represent the same cell line. For example, Cell line 17/14
(accessioned HB-8153 in ATCC catalog) is not the same
cell line as 171-4 (accessioned HB-296 in ATCC catalog).
Normalizing these two cell lines by removing punctuation
marks will result in a false normalization [14]. After
extracting annotations and related information from the
three resources, the mapping pipeline was divided into
three consecutive steps.
EFO-Cellosaurus-CLO mapping
In order to achieve cell line mapping with high confi-
dence and quality, a three-way mapping among EFO,
CLO and Cellosaurus was first performed (Step 2,
process (i) in Fig. 1). Only EFO and CLO cell lines with
unique cross reference to Cellosaurus were aligned in
this step, and EFO cell lines with multiple non-unique
cross references to Cellosaurus were directly matched
against CLO in the following step for validation. Due to
limited cell line information available in Cellosaurus,
only cell line annotation property values (name,
synonyms, and cross reference) and the common infor-
mation shared in both EFO and CLO (disease and spe-
cies of origin) were checked to validate the mapping.
Furthermore, if the diseases, each defined for a cell line
from each resource, had a direct subclass-superclass re-
lationship, these two diseases would be considered as
matched. For example, the cell line “NCI-H2087” had
three different disease definitions, “lung carcinoma”,
“lung adenocarcinoma” and “adenocarcinoma” in EFO,
Cellosaurus and CLO, respectively (Fig. 3). The direct
matching of this cell line between EFO and CLO would
not be valid because of the poorly defined disease associ-
ation, but such mapping could be recovered by the direct
subclass-superclass relation of diseases in EFO-
Cellosaurus (“lung carcinoma” to “lung adenocarcinoma”)
and CLO-Cellosaurus (“adenocarcinoma” to “lung adeno-
carcinoma”). Cell lines that had unmatched cell line anno-
tations or cell line related information were manually
verified.
Direct EFO-CLO mapping
EFO cell lines that were not processed in the previous
step were directly mapped to CLO cell lines (Step 2,
process (ii) in Fig. 1). A confidence score (C-score) was
developed to score the confidence of mapping between
an EFO cell line and all CLO cell lines.
Fig. 3 Example EFO-CLO cell line mapping recovered by Cellosaurus disease definition and semantics matching. There were three different disease
definitions (“lung carcinoma” in EFO, “lung adenocarcinoma” in Cellosaurus and “adenocarcinoma” in CLO) for the cell line “NCI-H2087”. The
direct mapping using cell line annotations, disease and species of origin would have gone undetected if we directly compared EFO cell line
disease information to CLO’s information. Discrepancies of cell line-disease annotation can be recovered through EFO-Cellosaurus-CLO disease
semantic relations
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SLD is shortest Levenshtein distance (SLD) among all
the combinations of EFO and CLO cell line labels and
synonyms [15]. In brief, the Levenshtein distances were
computed for every pair of cell line names (label or syn-
onyms) from EFO and CLO, and the smallest Levensh-
tein distance was selected as the SLD. In the case of an
exact label and synonyms match or an exact cross refer-
ence match of the EFO and CLO cell line, the value of
SLD is zero. M is a function indicating whether the ith
cell line related element in K was matched (+1) between
EFO and CLO cell line, or unmatched (−1). K contained
the cell line related information including diseases, cell
type, anatomic location and species of origin extracted
from the corresponding ontologies. The C-scores of each
EFO cell line against all CLO cell lines were computed.
For example, the mapping between EFO cell line
(EFO_0002208) NIH3T3 and CLO cell line NIH-3 T3
(CLO_0004301) had SLD of 1 (insertion of a special
character, “-”) and
PK
i¼1M of +3 (matched disease, ana-
tomic location and species of origin; missing cell type in-
formation), which gave a C-score of +2. Since it is too
labor intensive to go through thousands of EFO-CLO
matches for one EFO cell line, only top three CLO cell
lines with the best C-scores mapped to an EFO cell line
were inspected. Based on the calculated C-score, the
mapping could be summarized into three categories:
exact cell line annotation match with valid cell line re-
lated information match; exact cell line annotation
match with invalid cell line related information match
that required manual validation; inexact cell line annota-
tion match that required manual selection from the top
three mapped CLO cell lines. The remaining unmapped
EFO cell lines after manual selection then go through
the last step of the mapping pipeline.
Identification of additional EFO immortalized permanent
cell lines
Since there are biological and modeling differences be-
tween primary cell lines and immortalized permanent
cell lines, it is necessary to check whether the remaining
unmapped cell lines from the previous step were in fact
immortalized permanent cell lines or not. There is not
an explicit statement that distinguishes immortalized cell
lines from primary cell lines in the EFO cell line classes.
The identification of additional immortalized permanent
cell lines from EFO was done by cross referencing to
Cellosaurus since primary cell lines are not curated in
the Cellosaurus (Step 2, process (iii) in Fig. 1). Therefore,
if there is a traceable record of the cell line in Cello-
saurus, we made an assumption of it being a permanent
immortalized cell line and should be added to CLO.
EFO cell lines with cross reference in the Cellosaurus
that are not listed in the cell type category of “stem cell”
were considered as “immortalized permanent cell line”
and would be added to CLO, relying on the high-quality
cell line annotations manually curated in the Cellosaurus
for verification. Cellosaurus is a comprehensive collec-
tion of permanent cell lines and does not contain hier-
archical classification, we could not assume a
subClassOf relationship for these cell lines. For EFO cell
lines that were under the “stem cell” category or not
cross-referenced in Cellosaurus would be kept in the
EFO namespace because CLO does not yet support stem
cell derived cell lines. Additionally, the EFO cell lines
without Cellosaurus cross references were manually veri-
fied to be primary cell lines. The scope CLO is to cover
immortalized permanent cell lines deposited in major
cell line repositories such as ATCC, Coriell, HyperCLDB
and Riken, and does not have the design patterns for pri-
mary cell lines nor stem cell and stem cell derived cell
lines. Therefore, these EFO primary cell lines, as well as
the stem cell and stem cell derived cell lines were not
mapped to CLO.
Programming implementation
Alignment by cross-referencing between CLO and EFO
was mined from Cellosaurus knowledgebase. The source
files of EFO and CLO were then processed for ontology
class property alignment. A set of regular expression
rules were designed for normalization of special charac-
ters and comparison of cell line rdfs:label property. The
semantics and other biological information enriched by
CLO’s and EFO’s design patterns were retrieved and
compared using the OWL API library [16]. The changes
reflecting the EFO-CLO alignment will be updated in
CLO and deposited onto CLO GitHub repository where
EFO can further subsume and import into EFO re-
placing locally identified terms. Permanent URLs (PURL)
of both ontologies are also resolved on the EMBL-EBI
Ontology Lookup Service (OLS) [17], the EMBL-EBI
RDF Platform [18] and the Ontobee [11]. All informa-
tion can be queried using SPARQL in Ontobee SPARQL
endpoint (http://www.ontobee.org/sparql).
Building cell line design pattern
Cell lines in CLO and EFO have different naming strat-
egies. In EFO, cell line naming convention is a mix of in-
dividual cell implication (e.g., HEK-293 cell), or a cell
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line name with no indication of cell population (e.g.,
MCF 10A). CLO focuses on the definition of individual
‘cell line cell’ and its laboratory-derived descendants.
CLO:‘cell line’ is a population of CLO:‘cell line cells’. The
definition of ‘cell line cell’ targets individual single cells,
which offers the advantage of using CLO’s design pattern
in single cell profiling data representation. Therefore,
the aforementioned EFO’s cell line examples would be
converted to ‘HEK-293 cell’ and ‘MCF 10A cell’ accord-
ing to CLO’s naming convention to aid normalization
between the two resources. The normalization also im-
proves the readability and clarity of EFO cell line names
when working in OBO space.
The design patterns of both EFO and CLO were simi-
lar with some minor variation, and CLO design pattern
was used as the template to bridge EFO unique features
(Fig. 2). First, a cell line in CLO was defined as a bio-
logically individual cell (“cell line cell”) while in EFO
cell line was described as cell populations (“cell line”),
and the two classes were linked by object property “has
grain” in CLO. Even though cell line related biological
information was mostly shared between EFO and CLO,
two minor differences existed. First, EFO uses the ob-
ject property “bearer of” to model disease while CLO
uses “is model for”. Second, CLO “cell line cell” was
“derives from” the CL class “cell” which can be “cell
type” or another “cell line cell” (which is also a cell
type), but in EFO “cell line” was “derives from” only
“cell type”. Therefore, aligning EFO with CLO by
importing CLO classes into EFO required adjustment
within EFO so the differences in the two cell line design
patterns were resolved.
Results
The results of the three intermediate steps, (i) EFO-
Cellosaurus-CLO mapping, (ii) Direct EFO-CLO Map-
ping and (iii) Identify EFO Unique Cell Lines were illus-
trated in Fig. 4. The overall mapping result was
summarized in Table 1. In conclusion, there were 874
EFO-CLO mapped cell lines aligned and cell line related
information would be merged into CLO and 344 EFO
unique immortalized permanent cell lines added to CLO
(Additional file 2: Table S2). These merged or added
EFO-CLO cell lines could be imported from CLO as the
immortalized permanent cell line module into EFO with
enriched cell line information integrated from EFO and
CLO. Since CLO does not cover primary cell lines nor
stem cell and stem cell derived cell lines, the 66 stem
cell lines and 32 primary cell lines identified at the end
of this study would remain in the EFO namespace until
further investigation.
Fig. 4 Mapping results of the three intermediate processes (i)-(iii) in Step 2 of the overall workflow. (i) EFO-Cellosaurus-CLO Mapping shown with
diamond pattern. (ii) Direct EFO-CLO Mapping was the region with diamond pattern. In this intermediate process. (iii) Identify EFO Unique Cell lines
was the shaded region overlapped with (ii). All the unmatched EFO cell lines from (ii) were processed in (iii) to identify EFO unique immortalized
permeant cell lines that would be added to CLO
Table 1 EFO-CLO cell line mapping results. The EFO-CLO mapping
result from Step 2 (dotted frame) of Fig. 1. The EFO-CLO mapped
cell lines and EFO unique immortalized permanent cell lines were
to be merged or added into CLO. The imported cell lines (EFO cell
lines with foreign CLO or BTO namespace), stem cell lines and
primary cell lines would be kept in EFO core ontology
Type of Mapping Result # of Cell Line
EFO-CLO Mapped Cell Lines 873
EFO Unique Immortalized Permanent Cell Lines 344
Imported Cell Lines 448
Stem Cell Lines 66
Unmapped Cell Lines 32
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Improved cell line mapping by biological and semantic
content
Using the 624 cell lines in the EFO-Cellosaurus-CLO
mapping step as the gold standard, we compared and
evaluated the improvement of cell line mapping when
biological information and semantic relationship were
incorporated into the mapping process. By using the cell
line annotation alone (label, synonyms and cross refer-
ences), 439 out of 624 cell lines were mapped. An add-
itional of 130 cell lines were recovered by integrating
biological information and semantic relationship of dis-
ease definition. The percent mapping was improved
from 70.4 to 91.2% when the biological and semantic
content was added on top of the lexical and cross refer-
ence mapping criteria.
Comparison of design patterns
To illustrate the similarities and differences between
CLO and EFO, an example of the aligned cell line,
“MCF 10A” is described to facilitate the comparison
(Fig. 2). MCF 10A is a non-tumorigenic epithelial cell
line derived from mammary gland [19]. In EFO, MCF
10A (EFO_0001200) is directly classified under ‘cell line’
while the CLO ‘MCF 10A cell’ (CLO_0007599) is de-
fined as ‘cell line cell’, and their design patterns are de-
scribed in Fig. 5. In addition, the CLO cell line class is
also a sub-class of ‘immortal human breast epithelial cell
line cell’. From the parent term, CLO’s MCF 10A cell in-
herits the information of human breast epithelial cell.
The CLO also includes a more detailed hierarchical
definition between ‘cell line cell’ and ‘immortal human
breast epithelial cell line cell’ but missing the specific or-
ganism part of mammary gland which can be drawn
from EFO. Integration of the information from EFO and
CLO will enrich the knowledge of the cell line and sup-
port better classification.
Discussion
We have developed a mapping process that combines
third-party cross referencing, lexical and biological con-
tent comparison, and semantic relation matching in
order to compare, align and synchronize immortalized
permanent cell lines available in EFO and CLO. In this
study, 92.6% (1218 out of 1315) EFO native immortal-
ized permanent cell lines were either aligned or added to
CLO. The complementary information integrated from
EFO and CLO provided a more comprehensive coverage
of immortalized permanent cell lines and their related
biological information. In addition, the imported CLO
immortalized permanent cell lines defined as the bio-
logically individual cell can help EFO to better represent
and model single-cell experiments.
Manual curation of the mapping between ontologies is
time consuming, as illustrated here in cell line mapping
between EFO and CLO. Our study also proposed an ap-
proach to discover new EFO-CLO cell line mapping
exploiting the confidence score (C-score) that integrated
cell line lexical and semantic information to aid the
process of building semi-automated mapping pipeline.
Thus, our study illustrated the advantage of utilizing
Fig. 5 MCF 10A design patterns in EFO and CLO. The EFO cell line design pattern was colored in orange and CLO in blue. The white text inside
each box showed the aligned cell line “MCF 10A” (EFO accession: EFO_0001200; CLO accession: CLO_0007599) with different axiomatized biological
information. Additionally, “MCF 10A” cell line cell was defined as “subclass of” CLO “immortal human breast epithelial cell line cell”, which added further
biological information after hierarchy inference
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biological content stored as semantic relations in ontol-
ogy over just lexical comparison for cell line mapping.
Using the EFO-Cellosaurus-CLO cross referenced cell
lines as the gold standard. In this study, 91.2% of the
EFO-CLO cell lines were mapped and validated. Our
pipeline that integrated cell line-related biological infor-
mation and its semantic relations showed improved
mapping performance as to lexical matching only. Even
though the design of this pipeline is specific for the cell
line mapping from EFO to CLO, the usage of biological
content and semantic relations defined in the ontol-
ogies could be generalized. For example, such informa-
tion can be applied to probabilistic mapping tools using
Bayesian network [20, 21] and Markov network [22]
based approaches.
In addition, biological information of a cell line can be
examined by their ontology relations to improve the ac-
curacy of the mapping. For example, cell line ‘SW684’ is
defined in both EFO and CLO. In EFO, this cell line
(EFO_0002369) is derived from ‘connective tissue’. The
same cell line in CLO (CLO_0009198) is derived from
some ‘fibroblast’. In Cell Ontology (CL) [23], the term
‘fibroblast’ (CL_0000057) is a sub-class of CL term ‘con-
nective tissue cell’ (CL_0002320). Therefore, these two
EFO and CLO cell lines can be matched by axiomatiza-
tion alignment through the biological information pro-
vided by CL. The use of ontology in optimal hierarchy
identification can further support better cell line map-
ping performance.
Cell line naming in different laboratories remains an
issue of inconsistency, and can lead to repeated usage of
cell line names. In our study, we identified two occur-
rences of the cell line name “H9”. The CLO “H9” cell
line is an immortalized human T-cell lymphoma cell line
deposited with American Type Culture Collection
(ATCC) [24]. The EFO “H9” cell line is a human embry-
onic stem cell derived from human blastocysts registered
in NIH Human Embryonic Stem Cell Registry [25]. Due
to the lack of cell line nomenclature standardization or
label-usage control by centralized authorities, cell lines
derived under different experimental conditions from
different organizations at different time points may share
the same textual label. Such duplicated cell line labels
could lead to confusion when modeling and reporting
experimental results. The ambiguity of cell lines should
be addressed to identify a differentia to be coded onto the
ontology, or by a naming authority of consensus [14, 26].
Another issue throughout the mapping of EFO and
CLO cell lines was the imprecise disease definition of a
cell line from different resources. This will continue to
be a major challenge as modeling of diseases is very dif-
ficult due to the dynamic of definition establishment that
vary in different clinical communities and expertise.
Though much needed, establishing a framework that
consolidates the different aspects of disease semantics to
be modeled with a common disease ontology is out of
the scope of this study. Attempts to find a common
ground that consolidates multiple disease vocabularies
have been initiated in various projects such as the Mon-
arch Initiative Disease Ontology [21], and the EBI
Ontology-cross-Ontology cross-reference mapping ser-
vice (https://www.ebi.ac.uk/spot/oxo/). Establishing a
framework for common disease ontology remains a
practice requiring community agreement at large.
Conclusions
In this study, a mapping process was developed order to
compare, align and synchronize immortalized permanent
cell lines available in EFO and CLO. The mapping pipe-
line combined third-party cross referencing, lexical and
biological content comparison, and semantic relation
matching in. A total of 92.6% EFO native immortalized
permanent cell lines were either aligned or added to
CLO, and the complementary information was merged.
The imported CLO immortalized permanent cell lines
defined as the biologically individual cell can help EFO
to better represent and model single-cell dynamic under
varied experimental conditions.
Additional files
Additional file 1: Table S1. EFO cell lines drawn from external sources.
In the initial step of the EFO-CLO comparison and alignment process,
there are 428 and 20 EFO cell lines which were imported from Cell Line
Ontology and 20 in BRENDA Tissue and Enzyme Source Ontology respectively.
These 448 EFO cell lines were excluded from the entire mapping process. File
is stored in Microsoft Excel spreadsheet (xlsx) format. (XLSX 47 kb)
Additional file 2: Table S2. Final EFO-CLO alignment result. The 874
EFO-CLO mapped cell lines aligned and merged into CLO (Tab. 1 in the
excel file) and 344 EFO unique immortalized permanent cell lines added
to CLO (Tab. 2 in the excel file). File is stored in Microsoft Excel spreadsheet
(xlsx) format. (XLSX 54 kb)
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